These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 11790270

  • 1. Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy.
    Rosano GM, Fini M.
    Cardiol Rev; 2002; 10(1):51-60. PubMed ID: 11790270
    [Abstract] [Full Text] [Related]

  • 2. Cardioprotective effects of ovarian hormones and the HERS in perspective.
    Rosano GM, Graziottin A, Fini M.
    Maturitas; 2000 Apr 01; 34 Suppl 2():S3-10. PubMed ID: 10915917
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women.
    Contreras I, Parra D.
    Am J Health Syst Pharm; 2000 Nov 01; 57(21):1963-8; quiz 1969-71. PubMed ID: 11094650
    [Abstract] [Full Text] [Related]

  • 7. Postmenopausal hormone therapy and the cardiovascular system.
    Speroff L, Lobo RA.
    Heart Dis Stroke; 1994 Nov 01; 3(3):173-6. PubMed ID: 8044433
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC.
    Womens Health Issues; 1992 Nov 01; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [Abstract] [Full Text] [Related]

  • 12. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study.
    McPherson R.
    Can J Cardiol; 2000 Jan 01; 16 Suppl A():14A-9A. PubMed ID: 10653926
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N, HERS Research Group.
    JAMA; 2002 Jul 03; 288(1):49-57. PubMed ID: 12090862
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Estrogens should not be initiated for the secondary prevention of coronary artery disease: a debate.
    Hulley S.
    Can J Cardiol; 2000 Aug 03; 16 Suppl E():10E-12E. PubMed ID: 10906618
    [Abstract] [Full Text] [Related]

  • 17. Estrogens and progestins in postmenopausal women: influence on lipid parameters and cardiovascular risk.
    Bruckert E, Turpin G.
    Horm Res; 1995 Aug 03; 43(1-3):100-3. PubMed ID: 7721254
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Estrogens for prevention of coronary heart disease?].
    Meinertz T.
    Herz; 1997 Jun 03; 22(3):151-7. PubMed ID: 9303898
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.